Sugarless Pastilles with LYCASIN® Maltitol, PEARLITOL® Mannitol and Gum Arabic
Formulation Guideline

Sugarless Pastilles with LYCASIN® Maltitol, PEARLITOL® Mannitol and Gum Arabic

Formulation for sugarless pastilles that contain LYCASIN® 80/55 Maltitol Liquid, PEARLITOL® 160 C Mannitol and Gum Arabic

Formula:

 

Ingredient parts by weight (g)

Ingredient parts by weight (g)

 

Formula 1

Formula 2

LYCASIN® 80/55 maltitol liquid

906

842

PEARLITOL® 160 C mannitol

78

142

Gum Arabic

16

16

Active

qs

qs

Acid, flavor

qs

qs

Method:

  1. Incorporate the powder mixture (PEARLITOL® 160 C mannitol – gum arabic) into the cold LYCASIN® 80/55 maltitol liquid.
  2. Cook the mixture until water content of approximately 1-1.5% is obtained.
  3. Cool. Add acid and flavor.
  4. Cast or form.  

Additional comments:

  • The pastille can be packaged normally with good shelf life. Use of polyols can improve the chemical stability of this product.
  • The active is added at the propitious moment, as a function of its physical and chemical properties.
  • LYCASIN® maltitol liquids are widely used as a vehicle and humectant for syrups, suspensions and as bulk sweetener in lozenges and medicated confectionary. The natural sweetness and non-cariogenic property make LYCASIN® suitable to be used in formulation addressing all types of patient populations including pediatric and diabetic. In the pharmaceutical and nutraceutical industry, these maltitol liquids are also a sucrose replacement in preparations such as sugarless syrups, lozenges and jellies.
  • PEARLITOL® mannitol is used as a filler and filler/binder as well as a bulk sweetener. The PEARLITOL® range offers a unique blend of exceptional physical and chemical stability and no hygroscopicity. With great organoleptic, non-cariogenic and sugar-free properties, PEARLITOL® is suitable to be used in formulations addressing various patient populations including pediatric and diabetic. PEARLITOL® can be used in in various oral dosage forms in both pharmaceutical and nutraceutical applications including swallowable tablets, orally dispersible tablets, chewable tablets, effervescent tablets, lozenges, blends, granules, pellets premix and medicated confectionary.

Disclaimer:

This formula is a guideline for recommended use of our products; it does not imply consent to their use in violation of existing patent(s). 
These details are for information only, and we believe them to be reliable.